6 results
management hematology diagnosis hivaids infections opportunistic prevention anemia aplastic capsulatum carcinoma chemotherapy cyp3a4 doac hcc hepatocellular histoplasma histoplasmosis inducers inhibitors
Systemic Therapy for Hepatocellular Carcinoma - AGA Clinical Practice Guideline First Line Treatment for HCC with Preserved
First Line Treatment ... Function Second Line Treatment ... #Management #Hepatology ... #Gastroenterology ... #oncology #Pharmacology
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓) of cytochrome p450 CYP3A4 and P-glycoprotein. DOACs are substrates
interactions) Cancer-treatment ... #Chemotherapy #Oncology ... #Hematology #Interactions ... #Table #Pharmacology
Aplastic Anemia - Overview Who? • M = F • 3 peaks: 1) Childhood 2) 15-25 years 3) >60 years What? • Aplastic anemia
- Parvovirus B19 ... • Parvovirus B19 ... aplastic anemia Treatment ... Aplastic #Anemia #oncology ... #hematology #diagnosis
Myelodysplastic Syndromes (MDS) What? Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly
Nutritional: vitamin B12 ... factor (GCSF) treatments ... marrow studies Treatment ... #diagnosis #hematology ... #oncology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS Indications for Initiating Primary Prophylaxis: •
IDSA Recommendations ... BID for at least 12 ... with ARV (see Table ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS Treating LTBI (to prevent TB disease) Indications:
IDSA Recommendations ... 50 mg weekly x 12 ... Please refer to the table ... Tuberculosis #TB #IDSA ... infections #HIVAIDS #pharmacology
No results found for "b12 treatment gastroenterology table hepatology oncology syndrome pharmacology idsa"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #b12 #treatment #gastroenterology #table #hepatology #oncology #syndrome #pharmacology #idsa